All of the study patients revealed symptoms of HF (New York Heart Association [NYHA II] 71%; NT-proBNP 1180 (324–3310) pg/ml) and typical cardiovascular disease risk factors (hypertension [54%], dyslipidemia [80%], diabetes [51%], and chronic kidney disease [53%]). The gene discussed is NPPB; the disease is chronic kidney disease.